IN2014MU00215A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MU00215A IN2014MU00215A IN215MU2014A IN2014MU00215A IN 2014MU00215 A IN2014MU00215 A IN 2014MU00215A IN 215MU2014 A IN215MU2014 A IN 215MU2014A IN 2014MU00215 A IN2014MU00215 A IN 2014MU00215A
- Authority
- IN
- India
- Prior art keywords
- mucoadhesive
- relates
- tablet
- mucoadhesive tablet
- pregabalin
- Prior art date
Links
- 230000003232 mucoadhesive effect Effects 0.000 abstract 4
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 239000003349 gelling agent Substances 0.000 abstract 1
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 abstract 1
- 229960001233 pregabalin Drugs 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 abstract 1
- 230000008961 swelling Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IN2015/000033 WO2015114656A2 (en) | 2014-01-22 | 2015-01-20 | Mucoadhesive tablet of pregabalin |
| IN215MU2014 IN2014MU00215A (ru) | 2014-01-22 | 2015-01-20 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN215MU2014 IN2014MU00215A (ru) | 2014-01-22 | 2015-01-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MU00215A true IN2014MU00215A (ru) | 2015-08-28 |
Family
ID=53757863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN215MU2014 IN2014MU00215A (ru) | 2014-01-22 | 2015-01-20 |
Country Status (2)
| Country | Link |
|---|---|
| IN (1) | IN2014MU00215A (ru) |
| WO (1) | WO2015114656A2 (ru) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6919119B2 (ja) * | 2017-01-23 | 2021-08-18 | 日新製薬株式会社 | ３位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。 |
| CN108159011A (zh) * | 2018-03-16 | 2018-06-15 | 中国药科大学 | 一种双相控释的普瑞巴林胃滞留缓释片及其制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2765998A1 (en) * | 2011-10-11 | 2014-08-20 | Ranbaxy Laboratories Limited | A gastroretentive dosage system and process of preparation thereof |
-
2015
- 2015-01-20 WO PCT/IN2015/000033 patent/WO2015114656A2/en active Application Filing
- 2015-01-20 IN IN215MU2014 patent/IN2014MU00215A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015114656A2 (en) | 2015-08-06 |
| WO2015114656A3 (en) | 2015-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12016501830A1 (en) | Inhibitors of c5a for the treatment of viral pneumonia | |
| PH12017501035A1 (en) | Method for the production of a pharmaceutical delivery system | |
| PH12016501841A1 (en) | Immunosuppressant formulation | |
| EP3102188A4 (en) | Novel disintegration systems for pharmaceutical dosage forms | |
| IN2014MU00303A (ru) | ||
| MA39710A (fr) | Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin | |
| IN2014DN06966A (ru) | ||
| MX2022015606A (es) | Comprimidos de liberacion inmediata que contienen un farmaco y procesos para formar los comprimidos. | |
| MX2017001487A (es) | Sofosbuvir en forma cristalina y proceso para su preparacion. | |
| MX2016015464A (es) | Composicion farmaceutica oral de isotretinoina. | |
| NZ725577A (en) | Modified release coated capsules | |
| PH12016501059A1 (en) | A pharmaceutical composition containing combinations of nicotinamide and 5-aminosalicylic acid for beneficially influencing the intestinal microbiota and/or treating gastrointestinal inflammation | |
| MX2017004312A (es) | Composicion farmaceutica oral de baja dosis de isotretinoina. | |
| NZ725578A (en) | Modified release coated capsules | |
| SG11201609948YA (en) | Lobaplatin crystal, preparation method and pharmaceutical application | |
| PL3237375T3 (pl) | Kryształy prekursorów N-(kwas octowy) alaniny, sposób ich wytwarzania i ich zastosowanie | |
| MX2017007245A (es) | Metodos de tratamiento de la fibrosis. | |
| IN2014MU00215A (ru) | ||
| EA202090913A1 (ru) | Композиция таблеток с модифицированным высвобождением, содержащая мирабегрон | |
| PH12016502272A1 (en) | Ceritinib formulation | |
| SI3236952T1 (sl) | Farmacevtski sestavek v obliki tablet | |
| MX2014005153A (es) | Proceso de obtencion y composicion farmaceutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor. | |
| IL250419A0 (en) | Use of a pill/tablet/capsule of minocycline, plataconazole and atorvastatin in the treatment of multiple sclerosis | |
| IN2014MU00198A (ru) | ||
| MX2016006742A (es) | Composicion farmaceutica. |